Sanofi Q4 Preview: CEO Hudson’s Planned Revamp Key Focus
Investors Seek More Details From Sanofi’s Top Exec On Growth Strategy
Executive Summary
Sanofi’s Q4 update will highlight planned strategic changes and Dupixent’s key growth role, amid a strong rebound in quarterly US flu vaccine sales.